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DISSERTATION ABSTRACT 
 
Ye Yang 
 
Doctor of Philosophy 
 
Department of Biology 
 
June 2013 
 
Title: Investigation into the Regulation and Function of Alkaline Phosphatase (ALP) in 
Host-Microbe Interactions 
 
 
This dissertation describes our investigation into the regulation and function of 
the innate immune modulator alkaline phosphatase (ALP). Animal intestine harbors a 
vast and complex microbial community, the gut microbiota. While resident microbes 
perform vital functions and confer tremendous benefits on their hosts, they also provide 
antigens and toxins that provoke host immune responses, which, if uncontrolled, could be 
detrimental to the host. Our lab previously demonstrated a negative feedback loop 
mediated by intestinal ALP (ALPI) which promotes immune tolerance to the commensal 
microbiota in zebrafish. We continue to investigate regulation mechanisms of ALP genes 
and explore their roles in modulating host-microbe interactions in various models. We 
have characterized four zebrafish alp genes, and we engineered tools for functional 
studies of these genes. Phylogenic analyses involving zebrafish alp genes revealed 
distinct evolution histories of animal ALP genes and implied their diversified functions. 
We then tested whether the regulation mechanism and the roles of zebrafish alpi were 
conserved in mice. We found the ALPI gene Akp3 was specifically upregulated by 
microbiota and played a role in immune education. We demonstrated the contribution of 
innate immune signaling to animal weight gain induced by high fat diet feeding. Finally, 
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we discovered the positive correlation between neonatal ALPI activity and gestational 
age, suggesting potential therapeutic value of ALP supplementation for preventing 
necrotizing enterocolitis development in preterm infants. 
This dissertation includes previously published and unpublished co-authored 
material. 
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CHAPTER I 
INTRODUCTION 
 
The Mutually Beneficial Relationship Forged between Host and the Gut Microbiota 
Requires Fine-Tuning of Host Immune Responses 
Vertebrates live in symbiosis with a consortium of microorganisms, the 
microbiota. The most populous microbial community is present in the intestine. The 
human intestinal microbiota are comprised of as many as 1,000 distinct species and 100 
trillion microorganisms, dominated by bacteria (Turnbaugh et al., 2007). A mutually 
beneficial relationship has been forged between the host and its associated gut 
microbiota. While the host intestine provides a hospitable and nutrient-rich environment 
for the microbes, the gut microbiota modulate host nutrient intake and metabolism 
(Backhed et al., 2005; Tremaroli and Backhed, 2012), promote maturation of the innate 
and adaptive immunity (Jarchum and Pamer, 2011), preserve the intestinal epithelial 
barrier function (Sharma et al., 2010), and prevent growth of pathogens and abnormal 
microbiota (Stecher and Hardt, 2011).  
Despite these benefits, the intestinal microbiota are a continuous source of 
antigens and toxins that have the potential to provoke host inflammatory responses. One 
classic example is the activation of host innate immune responses by bacterial 
lipopolysaccharide (LPS). LPS, also referred to as endotoxin, is a constituent of the outer 
membrane of Gram-negative bacteria (Elin and Wolff, 1976) and abundantly present in 
the intestine. LPS is a classic microbial associated molecular pattern (MAMP) and potent 
inducer of innate immune signaling in both vertebrates and invertebrates (Beutler and 
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Rietschel, 2003). In mammals, LPS binds specifically to a complex consisting of Toll-
like receptor 4 (TLR4) and MD-2 through two phosphate groups of its lipid A moiety 
(Kim et al., 2007; Park et al., 2009), and induces inflammatory responses by activating 
two distinct pathways, namely NF-κB (through MyD88-dependent and independent 
pathways) and IRF-3 (through TRIF/TRAM).  
Uncontrolled inflammatory responses to the resident microbiota could damage the 
beneficial microbes and be detrimental to host. Regulatory mechanisms must exist to 
prevent unlimited immune activation. On the other hand, irresponsive immunity may fail 
to defend against invading pathogens. A delicate balance between the proinflammatory 
and immunosuppressive responses must therefore be actively maintained by both host 
and microbes to achieve a healthy steady state in which the gut microbiota are tolerated 
and simultaneously well restrained (Chow et al., 2010; Pamer, 2007; Round and 
Mazmanian, 2009; Sansonetti, 2004).  
 
Alkaline Phosphatase (ALP) Mitigates Host Inflammatory Responses to Bacteria by 
Dephosphorylating LPS 
Alkaline phosphatases (ALPs) are a superfamily of metalloenzymes that are 
widely found in organisms ranging from bacteria to human (McComb RB, 1979) and 
catalyze the hydrolytic removal of phosphate from a variety of molecules (Millan, 2006). 
Importantly, ALPs have been shown to remove the lipid A phosphates of LPS (Bentala et 
al., 2002; Riggle et al., 2013; Tuin et al., 2009; van Veen et al., 2006). By 
dephosphorylating LPS, ALPs decouple LPS and the TLR/MD-2 receptor complex, 
thereby ameliorate LPS-induced inflammation and reduce LPS endotoxic properties 
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(Lukas et al., 2010; Park et al., 2009; Poelstra et al., 1997a; Poelstra et al., 1997b; Rader 
et al., 2012; Riggle et al., 2013; Tuin et al., 2009). The LPS dephosphorylation activity 
could also explain the protective effects of ALPs against various inflammation-related 
injuries (Bates et al., 2007; Bol-Schoenmakers et al., 2010; Campbell et al., 2010; 
Heemskerk et al., 2009; Kats et al., 2009; Lukas et al., 2010; Martinez-Moya et al., 2012; 
Pickkers et al., 2012; Ramasamy et al., 2011; Rentea et al., 2013; Rentea et al., 2012a; 
Rentea et al., 2012b; Riggle et al., 2013; Tuin et al., 2009; van Veen et al., 2006; van 
Veen et al., 2005; Verweij et al., 2004; Whitehouse et al., 2010). 
The mammalian ALP family consists of several isozymes that can be classified 
into tissue-nonspecific ALPs (liver-bone-kidney type) and tissue-specific ALPs 
(intestinal, placental, and germ cell type) (Yang et al., 2012). The intestinal ALP (ALPI) 
is abundantly present in the apical microvilli of the brush border of enterocytes (Hanna et 
al., 1979), and actively secreted into the intestinal lumen (McConnell et al., 2009; Shifrin 
et al., 2012). The physiological location of ALPI at the interface between the intestinal 
tissue and the gut microbiota suggests its involvement in shaping and sustaining the host-
microbe mutualism in the intestine. Recent studies have shown that ALPI regulates 
neutral pH in the intestine (Mizumori et al., 2009), protects gut barrier function 
(Goldberg et al., 2008; Kaliannan et al., 2013; Martinez-Moya et al., 2012; Rentea et al., 
2012b), preserves the normal homeostasis of the gut microbiota (Malo et al., 2010), and 
dephosphorylates proinflammatory molecules including nucleotide uridine diphosphate 
(Moss et al., 2013), flagellin (Chen et al., 2010), unmethylated cytosine-phosphate-
guanine deoxyribonucleic acid (CpG DNA) (Chen et al., 2010), and of course, LPS.  
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The anti-inflammation role of ALPI is supported by many observations. Cell 
culture studies showed that in human intestinal epithelial cells (i.e., HT-29, T84 and IEC-
6) overexpressing ALPI, LPS-activated NF-κB nuclear translocation was significantly 
inhibited (Goldberg et al., 2008). At the whole animal level, administration of bovine 
ALPI proved to reduce local/systemic inflammation and improve tissue morphology in 
the mouse polymicrobial sepsis model induced by cecal ligation and puncture (van Veen 
et al., 2005), in the rat liver ischemia–reperfusion model (van Veen et al., 2006), in the 
murine chronic colitis model induced by dextran sulfate sodium (DSS) (Campbell et al., 
2010; Ramasamy et al., 2011; Tuin et al., 2009) or TNBS (Martinez-Moya et al., 2012), 
and in the neonatal necrotizing enterocolitis rat models (Rentea et al., 2013; Rentea et al., 
2012a; Rentea et al., 2012b; Riggle et al., 2013; Whitehouse et al., 2010). In human 
clinical trials, exogenous ALPI exerted protective anti-inflammatory effects on patients 
after cardiopulmonary surgery (Kats et al., 2009), patients with moderate to severe 
ulcerative colitis (Lukas et al., 2010) and patients with severe sepsis or septic shock 
(Heemskerk et al., 2009; Pickkers et al., 2012). Collectively, these findings confirm that 
ALPI is an important innate immune regulator, both locally and systemically.  
 
ALPI Contributes to Maintaining the Peaceful Relationship between Zebrafish and 
the Resident Microbiota 
Our studies using zebrafish larvae have demonstrated an integral role of ALPI in 
maintaining peace between host immunity and the gut microbiota (Bates et al., 2007; 
Bates et al., 2006). We showed that intestinal colonization of Gram-negative bacteria 
upregulated zebrafish ALPI gene alpi.1 through the LPS-induced innate immune 
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signaling, which requires the common TLR adaptor protein Myd88, and that ALPI 
functioned to dampen zebrafish inflammatory responses to the resident gut microbiota. 
The LPS-ALPI negative feedback loop therefore promotes zebrafish immune tolerance to 
the commensal Gram-negative bacteria.  
Several interesting questions then arise. What are the roles of other ALP genes in 
zebrafish? Is the ALPI-mediated anti-inflammatory innate immune response conserved in 
mammals? What is the implication of ALPI in human necrotizing enterocolitis (NEC)? 
To answer these questions, we have explored the regulation and function of different ALP 
genes in various systems. Chapter II describes characterization of zebrafish ALP genes 
and includes previously published material that was co-authored with A. M. Wandler, J. 
H. Postlethwait and K. Guillemin. Chapter III covers the study of mouse ALPI gene Akp3 
in host-microbe interactions and includes material that will be published with co-authors 
J. Mecsas, J. Sonnenburg, J. L. Millán, and K. Guillemin. Chapter IV reports the finding 
of ALPI deficiency in preterm neonates who are prone to NEC and includes material that 
will be published with co-authors, R. Bent and K. Guillemin. And finally, Chapter V 
summarizes the conclusions. 
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CHAPTER II 
CHARACTERIZATION OF ZEBRAFISH ALP GENES 
 
This chapter includes work previously published in Volume 3 of Frontiers in 
Immunology in October 2012 with co-authors A. M. Wandler, J. H.  Postlethwait and K. 
Guillemin. A. M. Wandler, K. Guillemin, and I designed the research. I characterized the 
four zebrafish ALP genes. J. H. Postlethwait performed phylogenic studies. K. Guillemin 
analyzed the microbiota profiles associated with different mammals. K. Guillemin, J. H. 
Postlethwait, and I wrote the paper. A. M. Wandler provided editorial assistance. 
 
Introduction 
The broad spectrum of substrates ALPs are able to dephosphorylate suggests 
versatile roles of ALPs. Distinct expression patterns of animal ALP genes further indicate 
their diversified functions. For example, while ALPI has been extensively studied for its 
anti-inflammatory role in health and disease, the tissue-nonspecific ALP (ALPL) is well 
recognized for its role in osteogenesis by promoting bone mineralization (Whyte, 2010). 
To dissect out how various ALP genes function in host-microbe interactions, we 
characterized ALP genes in zebrafish. The phylogeny study involving these genes 
revealed the dynamic evolution of vertebrate ALPs. I have also developed protocols and 
engineered genetic tools for functional analyses of individual zebrafish ALP genes.   
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Materials and Methods 
Use of Vertebrate Animals 
All zebrafish experiments were performed using protocols approved by the 
University of Oregon Institutional Care and Use Committee, and followed standard 
protocols (Westerfield, 2007).  
 
Protein Sequence Alignment 
Protein sequences used in the alignment are obtained from Ensembl 
(http://www.ensembl.org). ClustalW (http://www.ebi.ac.uk/Tools/msa/clustalw2/) was 
used to align the following sequences: human ALPL (ENSP00000363973) and ALPI 
(ENSP00000295463); zebrafish Alpl (ENSDARP00000117214), Alpi.1 
(ENSDARP00000016216), Alpi.2 (ENSDARP00000070354), and Alp3 
(ENSDARP00000019098). 
 
Sanger Sequencing of Zebrafish ALP Gene Coding Sequences 
Fresh RNA was extracted from 7 dpf (days post fertilization) zebrafish larvae 
(illustra RNAspin mini kit, GE Healthcare). Total cDNA was synthesized using RNA as 
template (SuperScript III reverse transcription kit, Life technologies). The coding 
sequences of ALP genes were amplified from cDNA by PCR using Phusion DNA 
polymerase (Thermo Scientific). Primers used include: alplF: 5’-
ATGTGGGAATGTGGATGCTTTCTTG-3’, alplR: 5’- 
TCAGCAAAGCAGCCATTTGACC-3’; alpi.1F: 5’- 
ATGTGTTTGGTTTACGGTCGGGC-3’, alpi.1R: 5’- 
 8 
 
 
TCATCTCAAAACAAGCCAAAACACG-3’; alpi.2F: 5’- 
ATGGCCAAAACACAAGCCCTG-3’, alpi.2R: 5’-
CTAAATAAGAGCAGTAATGGAGGACATCAG-3’; alp3F: 5’- 
ATGTTTGCTGTCCGTGTGTCC-3’, alp3R: 5’- 
TCAGTGCAGTAAAATCCTCATCAGTG-3’. PCR products were evaluated by DNA 
gel electrophoresis for purity and then extracted from gel. The purified PCR products 
were cloned into the pCR
®
 - Blunt II TOPO
®
 vector (ZeroBlunt
® 
TOPO
®
 PCR Cloning 
kit, Life Technologies). Clones carrying ALP gene coding sequences were sequenced 
(Sequetech). The complete coding sequences were assembled using the plasmid editor 
ApE (http://biologylabs.utah.edu/jorgensen/wayned/ape/), and submitted to GenBank. 
 
PCR Detection of Zebrafish ALP Gene Transcription 
Total cDNA was synthesized from fresh RNA prepared from 7 dpf whole fish, 
dissected intestines, or carcasses with guts removed. Gene-specific primers were used in 
PCR to test the presence of gene transcripts (alplF: 5’-
TATTTCTTGGAGATGGGATGGGTG-3’, alplR: 5’-
TTCAAAGAGTTGTCTGGCGATGTC-3’; alpi.1F: 5’-
GCACCGCGCCAAAGCACAAG-3’, alpi.1R: 5’-CGGGCTTCGGAGGGCACATC-3’; 
alpi.2F: 5’-TGCGCTTTACGGAAACGGTCCA-3’, alpi.2R: 5’- 
TGCGCCATCGGGCCTTTAGC-3’; alp3F: 5’-ATGTTTGCTGTCCGTGTGTCC-3’, 
alp3R: 5’-ACGA GAAACCGCCTCATCCAG-3’). Equal amounts of cDNA (200 ng/µl, 
NanoDrop 1000) were added as template in PCR.  
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In Situ Hybridization 
Zebrafish cDNA was obtained as describe above and used in PCR to amplify a 
unique fragment of alpl (alpl-F: TTCCAGAGCAAGAGAAGCGG; alpl-R: 
GTCTTAGAGAGGGCGACGTG), alpi.1 (alpi.1-F: CGACCGGGCGATTCAGAGAG; 
alpi.1-R: TGGTGTACGGCTCAAGGCAC), alpi.2 (alpi.2-F: 
TCACTAACGGGACTCGACCT; alpi.2-R: AGGCCATAGCGTGAGGAATG) and alp3 
(alp3-F: CAGGGTCATCACTCCAGTCG; alp3-R: TCTGGACGCTTGTTGTTGGT). 
The purified PCR product was cloned into the pCR
®
 - Blunt II TOPO
®
 vector 
(ZeroBlunt
® 
TOPO
®
 PCR Cloning kit, Life Technologies) and validated by sequencing 
(Sequetech). The verified plasmid was used as template in PCR and T7 RNA polymerase 
binding sites were added to the gene fragment. Primers used include alpl-F: 
TTCCAGAGCAAGAGAAGCGGC, alplT7-R: 
GTAATACGACTCACTATAGGGGTCTTAGAGAGGG; ali.1p-F: 
CGACCGGGCGATTCAGAGAG, alpi.1T7-R: 
GTAATACGACTCACTATAGGGTGGTGTACGGCTCAA; alpi.2-F: 
TCACTAACGGGACTCGACCTGATGT, alpi.2T7-R: 
GTAATACGACTCACTATAGGGAGGCCATAGCGTGAG; and alp3-F: 
CAGGGTCATCACTCCAGTCGGGC, alp3T7-R: 
GTAATACGACTCACTATAGGGTCTGGACGCTTGTTG. The purified PCR product 
was used as template to synthesize the DIG labeled RNA probe (DIG RNA Labeling Mix 
(T7), Roche Applied Science).  
7 dpf zebrafish larvae were fixed in 4% PFA overnight at 4°C and then washed in 
1×PBST. Rinsed larvae were embedded in 1.5% agar and cryo-cut into 16 µm thick 
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sections. Sections were defrosted and air died overnight at room temperature. Diluted 
RNA probes were added on slides and incubated overnight at 70°C. After hybridization, 
slides were rinsed with the wash solution (1xSSC, 50% formamide, 0.1% Tween-20). 
Slides were then treated with the block solution (MABT, 2% blocking reagent, 20% heat 
inactivated sheep serum) for 3 hours. Following that, first antibody solution (AP 
conjugated anti-DIG) was applied to slides and incubated overnight at 4°C. Slides were 
then washed in AP staining buffer (5M NaCl, 1M MgCl2, 1M Tris pH 9.5, 20% Tween-
20) and incubated with NBT/BCIP color regents in the dark at 37°C. The color 
developing process was stopped by washing slides in PBST. Slides were then rinsed in 
ddH2O, dehydrated in ethanol and eventually mounted in Permount. Images were taken 
under a Nikon TE2000 inverted microscope with a CoolSNAP camera (Photometrics). 
 
Transgenic Zebrafish Lines 
Transgenic zebrafish lines were constructed following the Tol2kit protocol (Kwan 
et al., 2007). Briefly, full length coding sequences of alpi.1 and alpi.2 were amplified by 
PCR using AB/Tuebingen zebrafish cDNA as template. Additional rounds of PCR were 
designed to add the viral 2A peptide sequence (Provost et al., 2007) before the start 
codon, and then add attB2 sites to the 5’ end and attB3 sites to the 3’ end. Purified PCR 
products, after verification by sequencing, were used in the BP recombination reaction 
(Invitrogen) to generate 3’ entry clones. The tdTomato middle entry clone was obtained 
from Dr. Judith Eisen’s lab at the University of Oregon. The 5’ entry clone carrying the 
bactin2 promoter was obtained from Dr. Chi-bin Chien’s lab at the University of Utah, 
and the clone carrying the ifabpb2 promoter was generated by Zac Stevens in our lab. 
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Finally, specific 5’, middle and 3’ entry clones were combined in the LR recombination 
reaction (Invitrogen) to create the Tol2 constructs, which, after verified by sequencing, 
were injected with the Tol2 transposase into zebrafish embryos at one cell stage. 
Embryos positive for tdTomato were raised up and crossed to AB/Tuebingen zebrafish. 
The progeny were selected for tdTomato signal and glowers were kept as stable 
transgenic lines.   
 
Targeted Mutagenesis Using TALENs 
The following paired TALE sequences were designed to specifically bind regions 
in exon 2 of alpl, alpi.1, alpi.2, or alp3 using the online tool “Paired Target Finder” 
(https://tale-nt.cac.cornell.edu/node/add/talef-off-paired): alpl-TAL1RVD: 
HDNINNNGNGNNNGHDNGNNNNHDNIHDHDHDNGNGNN, alpl-TAL2RVD: 
NGNINGHDNGNINGHDNINNHDHDNGNNHDNNNGNGNG; alpi.1-TAL1RVD: 
NNNININGNNNNNNNINNNININNNNNINGHDHDHDNN, alpi.1-TAL2RVD: 
HDNGNNHDNINNHDNNNGHDHDNNNGHDNGNNNNHDHD; alpi.2-TAL1RVD: 
NNNNNGNINGNNNGNINININNNNHDNGNINININNNI, alpi.2-TAL2RVD: 
NNNGNGNNNININGNNNGHDNINGNGNNNINNNINNHD; alp3-TAL1RVD: 
NGHDNGNNNNNINNNNNININNNGHDNNNNHDNGHDNI, alp3-TAL2RVD: 
NNNINGNGNGNGHDHDNGNNHDNGHDNINNNINNHDHD. These TALEs were 
assembled and cloned into the TALEN backbone plasmid following the previously 
published protocol (Sanjana et al., 2012). The resulting plasmids, after verified by 
sequencing, were used as templates to make TALEN transcripts using the Ambion 
mMessage mMachine T7 Ultra Kit (Life Technologies). After purification, paired 
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TALEN transcripts targeting individual ALP genes were injected to zebrafish embryos at 
one cell stage.  
 
E. tarda and V. cholerae Infections  
The Edwardsiella tarda strain isolated from catfish was kindly provided by Dr. 
Carol H. Kim (University of Maine, Orono, ME) and the Vibrio cholerae strain was 
isolated from zebrafish water at the University of Oregon. Liquid cultures were grown 
overnight at 28 °C with shaking. Rifampicin-resistant colonies were selected by plating 
bacterial cultures on TSA plates containing 50 μg/ml rifampicin, and stocked in 15% 
glycerol at -80 °C. Liquid cultures of rifampicin-resistant E. tarda or V. cholerae were 
grown overnight at 28 °C with shaking, diluted 1:10 early next morning, grown for 
another 3 hours at 28 °C with shaking, and centrifuged in 50 ml tubes at 5,000 rpm for 10 
min to harvest bacteria. Bacteria were resuspended in zebrafish embryo medium (EM) 
(0.29 g/l NaCl, 0.013 g/l KCl, 0.048 g/l CaCl2·2H2O, 0.082 g/l MgCl2·6H2O, pH 7.2). 
Bacterial concentration was calculated based on absorbance at OD600 (1 OD600 = 10
9
 
cfu/ml). Zebrafish embryos were collected from natural crossings between AB/Tuebingen 
parent fish. At 3 dpf, 25 embryos were put into a 250 ml flask containing 50 ml EM, and 
infection was done in triplicate flasks by inoculating EM with E. tarda or V. cholera to a 
final concentration of 5×10
7
 cfu/ml. After inoculation, zebrafish mortality was monitored 
daily till 8 dpf and the results were analyzed using the Prism software (GraphPad).  
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Results 
The Four Zebrafish ALP Genes Are Distributed among Three Vertebrate ALP Gene 
Clades  
We had previously characterized two zebrafish alp genes, which we called alp 
(accession number NM_201007.1) on chromosome 11 and alpi (accession number 
NM_001014353.1) on chromosome 22, and had shown that the former gene is 
ubiquitously expressed and the latter is intestinal specific (Bates et al., 2007). BLAST 
searches against the subsequent refinement of the zebrafish genome sequence revealed 
two additional alp-related genes: zgc:110409 (accession number NM_001025188.1) on 
chromosome 22, and the most recently described alp-related gene (accession number 
XM_003201677.1) on unassembled Scaffold Zv9 NA903 that Ensembl annotated as 
“alpl”. All four genes likely encode enzymatically active ALPs based on their conserved 
ALP motifs. Protein sequence alignment against human ALPL and ALPI showed that 
active site residues and proposed metal-binding residues are invariant in the proteins 
encoded by the two human genes and four zebrafish genes (Figure 1, see Appendix A for 
all figures).  
To better understand the identity and origin of the four zebrafish alp-related 
genes, we investigated their evolutionary history. Phylogenetic analysis of vertebrate 
ALP protein sequences rooted on non-vertebrate chordate sequences revealed three 
distinct clades of ALP genes, the tissue-nonspecific ALPL clade, the intestinal ALPI 
clade, and the fish-exclusive ALP3 clade (Figure 2). Analysis of the four zebrafish alp 
genes within this phylogeny revealed that i) the chromosome 11 “alp” is a genuine 
ortholog of the human tissue non-specific gene ALPL; ii) the chromosome 22 “alpi” and 
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the neighboring “zgc:110409” are tandem duplicates derived from the ancestral alpi gene 
and represent co-orthologs of human ALPI;  and iii) the new Scaffold Zv9 NA903 alp 
annotated in Ensembl as “alpl” belongs to the Alp3 clade maintained in teleosts but lost 
in tetrapods.  
Based on these findings, we developed a new nomenclature for the four genes, 
i.e., the current “alp” is renamed alpl, “alpi” is alpi.1, “zgc:110409” becomes alpi.2, and 
“alpl” is alp3. We cloned and sequenced the complete coding DNA sequences of the four 
zebrafish alp genes and submitted to Genbank: alpl (accession number JX847415), alpi.1 
(accession number JX847416), alpi.2 (accession number JX847417), and alp3 (accession 
number JX847418). 
 
Three of the Zebrafish ALP Genes Show Enriched Expression in the Intestine 
We further explored the four zebrafish ALP genes by investigating their tissue 
expression patterns. We used semi-quantitative reverse transcription PCR to estimate the 
abundance of the transcripts in intestinal tissue (“I”) versus the rest of the body (referred 
to as carcass, “C”). Transcript levels of alpl were abundant in the carcass as well as the 
intestine (Figure 3A). In contrast, transcripts of the other three genes were enriched 
(alpi.1 and alpi.2) or exclusively expressed (alp3) in intestinal tissue (Figure 3A). We 
next performed in situ hybridization with gene-specific RNA probes to further examine 
the expression patterns of the four alp transcripts. Consistent with our previous analysis 
(Bates et al., 2007), we observed that alpl was diffusely expressed in many tissues 
(Figure 3B). Also, as we showed previously (Bates et al., 2007), alpi.1 was highly 
expressed in the intestine (Figure 3C). We also observed high levels of intestinal-specific 
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expression of alpi.2 (Figure 3C & D), indicating that the tissue-specific expression of this 
alpi co-ortholog has been maintained. Finally, we observed intestinal-specific expression 
of the teleost-specific alp3 gene (Figure 3C & E), suggesting that intestinal-specific 
expression of alp genes is an ancestral trait possessed by the single ALP gene found in 
non-vertebrate chordates (Yang et al., 2012). 
 
Development of Genetic Tools for Functional Study of Zebrafish ALP Genes  
To facilitate functional analyses of individual zebrafish ALP genes, we have made 
a collection of valuable reagents. We have successfully constructed three transgenic 
zebrafish lines overexpressing ALP genes: the bactin2p:tdtomato:2Aalpi.1 line, which 
have ectopic expression of alpi.1 in whole fish; the ifabb2p:tdtomato:2Aalpi.1 line, 
which have ectopic expression of alpi.1 in the intestine; and the 
ifabb2p:tdtomato:2Aalpi.2 line, which have ectopic expression of alpi.2 in the intestine. 
On the other hand, we have made efforts to mutagenize zebrafish alp genes using 
designed TALENs (transcription activator-like effector nucleases) (Sanjana et al., 2012). 
Given the high efficacy of our designed TALENs for targeted genome editing in 
zebrafish, as demonstrated by our preliminary study, we hope to get loss-of-function fish 
lines of each ALP genes in the near future.   
These genetically modified zebrafish will be examined for interactions with 
commensal microbiota, as well as responses to Gram-negative pathogens.  
 
 
 
 16 
 
 
Development of an Infection Model for Functional Study of Zebrafish ALP Genes 
To study roles of zebrafish ALPs in regulating animal responses to Gram-negative 
pathogens, we established a standard zebrafish infection model. Zebrafish larvae hatch 
and open mouths around 3 dpf. We thus inoculated 3 dpf zebrafish larvae by adding 
Gram-negative pathogens into zebrafish embryo medium so that bacteria entered and 
colonized fish guts through the orally route. Fish mortality was monitored daily till 8 dpf. 
We tested the Gram-negative pathogen E. tarda, which was associated with freshwater 
that causes a systemic infection in fish (Pressley et al., 2005), and the opportunistic 
Gram-negative pathogen V. cholerae, which was isolated from fish water at the 
University of Oregon. We found that inoculation with rifampicin-resistant E. tarda or V. 
cholerae produced reproducible survival curves (Figure 4).  
 
Discussion 
We have characterized four zebrafish ALP genes, one tissue-nonspecific (alpl) 
and three enriched in the intestine (alpi.1, alpi.2, and alp3). We developed a new 
nomenclature for the four genes based on their phylogenic traits. We found that the 
vertebrate ALP genes arose from a single ancestral ALP gene but diversified into three 
major clades in vertebrates: the ALPL clade which includes zebrafish alpl, the ALPI clade 
which includes zebrafish alpi.1 and alpi.2, and the ALP3 clade which includes zebrafish 
alp3 and is lost in tetrapods. While ALPL genes remained relatively stable across 
vertebrates, ALPI genes have undergone rapid evolution, especially in mammals.  
We speculate the basis for the dramatically different evolutionary histories of 
the tissue non-specific ALPL genes and the intestinal ALPI genes, which encode enzymes 
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with well-conserved catalytic activities, lies in their different patterns of tissue expression 
(Yang et al., 2012). The ubiquitously expressed ALPL plays an important role in bone 
mineralization in mammals and modest changes in ALP function at sites of bone 
mineralization could lead to deleterious phenotypes, possibly restricting the evolution of 
copy number variation of this gene once it became dedicated to this function. On the 
contrary, intestinal ALP genes that regulate metabolism and host-microbiota interactions 
are under strong evolutionary pressure derived from the dramatic changes in animal 
dietary, gut morphologies, associated microbial communities, and pathogens.  
To facilitate future functional studies of the diversified zebrafish ALP genes, we 
have engineered specific gene gain-of-function and loss-of-function fish. And a standard 
infection model was established to test requirements for individual zebrafish ALP genes 
in defending against infections and evaluate their potential protective effects.   
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CHAPTER III 
REGULATION AND FUNCTION OF MOUSE ALPI GENE AKP3 
 
This chapter includes work that will be published with co-authors, J. Mecsas, J. 
Sonnenburg, J. L. Millán, and K. Guillemin. K. Guillemin and I designed the research. I 
performed the experiments and analyzed the data. J. Mecsas provided the pathogen strain 
and gave instructions on the infection protocol. J. Sonnenburg provided conventional and 
germ-free mouse intestine tissue samples. J. L. Millán provided Akp3-KO mice. The 
writing is mine. K. Guillemin provided editorial assistance. 
 
Introduction 
The mouse genome contains four ALP genes: the tissue-nonspecific type Alpl, the 
embryonic Alppl2, the intestinal Alpi, and the duodenal Akp3 (Millan, 2006; Yang et al., 
2012). Alppl2, Alpi and Akp3 all contribute to the ALP activity in the mouse intestine, but 
exhibit distinct expression patterns (Narisawa et al., 2007). Alppl2 and Alpi are expressed 
immediately after birth throughout the intestine but enriched in the duodenum. In 
comparison, Akp3 expression starts around postnatal day 13-15 and is restricted in the 
duodenum. The concordant timing of Akp3 expression with weaning and the 
establishment of the adult gut microbiota in mouse led us to test the possibility that Akp3 
is induced by microbiota.  
The three murine Alpi genes, Alppl2, Alpi and Akp3, arose from recent gene 
duplication in the rodent lineage and are not direct orthologues of the human ALPI genes 
or the alpi genes in zebrafish (Yang et al., 2012). It is therefore likely that Akp3 has 
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acquired novel functions in evolution. Since the generation of Akp3
-/-
 mice (Narisawa et 
al., 2003), several studies have probed the role of Akp3 in animal health and disease. Like 
other ALPs, Akp3 has LPS dephosphorylation activity, and Akp3
-/-
 mice had significantly 
lower ALP enzyme and LPS dephosphorylating activities in stools and duodenal mucosa 
compared with wild type littermates (Goldberg et al., 2008). Akp3
-/-
 mice had increased 
gut permeability, which caused more LPS translocation from the intestinal lumen into the 
blood (Kaliannan et al., 2013). Consequently, Akp3
-/-
 mice displayed higher hepatic 
expression of MHC class II molecules (Chen et al., 2011) and signs of metabolic 
endotoxemia (Kaliannan et al., 2013). Akp3
-/-
 mice were also found to contain 
dramatically fewer and also different types of aerobic and anaerobic microbes in stools 
compared with wild type mice (Malo et al., 2010). Together, these observations from 
routinely maintained animals indicate that Akp3 plays a role in maintaining the normal 
gut barrier function and regulating the gut microbial composition. The role of Akp3 as a 
gut mucosal defense factor is more evident when mice were challenged. Compared to 
wild type mice, Akp3
-/-
 mice suffered from more severe gut mucosal disruption and 
higher bacterial translocation after ischemia/reperfusion injuries (Goldberg et al., 2008), 
and were more vulnerable in dextran sulfate sodium (DDS)-induced colitis (Ramasamy et 
al., 2011). Interestingly, Akp3
-/-
 mice showed immune tolerance to intraperitoneal LPS 
injection and resistance to Salmonella typhimurium infection (Chen et al., 2011).  
It is worthwhile to note that all the aforementioned results were obtained from 
full-grown mice but little is known about the biological relevance of Akp3 in developing 
animals. We therefore compared intestinal inflammatory responses of wild type and 
Akp3
-/-
 mice at different ages to resident microbiota, to orally administered LPS, and to 
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Gram-negative pathogen Yersinia pseudotuberculosis. Based on our previous 
observations in zebrafish (Bates et al., 2007), we speculated that the partial reduction in 
ALPI activity due to disruption of one ALPI gene could give rise to subtle inflammatory 
reactions to the microbiota in Akp3
-/-
 mice during development, which in the long run 
might alter their immune sensitivity to future challenges like LPS. And to test whether 
the reported resistance of Akp3
-/-
 mice to S. typhimurium infection is pathogen-specific, 
we tested the requirement of Akp3 for defending against infection by Y. 
pseudotuberculosis.  
Although Akp3
-/-
 mice appear normal under normal laboratory conditions, they 
had accelerated fat absorption and weight gain when maintained long term on a high fat 
diet (HFD) (Kaliannan et al., 2013; Narisawa et al., 2003). However, the underlying 
mechanism is not well understood. We proposed that the LPS-mediated innate immune 
signaling could provide a link between HFD feeding and the faster weight gain. Long-
term HFD feeding was shown to increase plasma LPS (Amar et al., 2008; Cani et al., 
2007; Erridge et al., 2007; Ghanim et al., 2009), and increasing plasma LPS alone by 
continuous infusion of LPS could induce mouse weight gain by a similar extent to HFD 
feeding (Cani et al., 2007). More direct evidence for implication of LPS-sensing in HFD-
induced weight gain come from the observation that loss-of-function mutation of Tlr4 or 
CD14 (a co-receptor required for LPS detection in mammals) protects mice against HFD-
induced obesity (Cani et al., 2007; Davis et al., 2008; Radin et al., 2008; Tsukumo et al., 
2007). We examined whether the dysregulated LPS/TLR4 signaling due to loss of Akp3 
contributed to the faster weight gain phenotype observed in Akp3
-/-
 mice receiving HFD. 
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Materials and Methods 
Mice 
Animals were maintained and all procedures were performed with approval of the 
University of Oregon Institutional Animal Care and Use Committee. Pairs of Akp3
+/-
 
C57BL/6 mice were obtained from Dr. José Luis Millán’s group (the Sanford-Burnham 
Medical Research Institute, La Jolla, CA). Generation of the Akp3
−/−
 mice was described 
previously and the genotyping protocol was established (Narisawa et al., 2003). Pairs of 
MyD88
+/-
 and CD14
+/-
 C57BL/6 mice were obtained from the Jackson Laboratory and 
genotyping was done following instructions described in JAX
®
 Mice database. 
Heterozygous mice were bred at the University of Oregon animal facility to acquire 
homozygous mutants and wild type littermates. For HFD feeding, a female Akp3
-/-
 mouse 
was crossed to a male CD14
-/-
 mouse to generate Akp3
+/-
;CD14
+/-
 mice, which were 
subsequently mated to produce progeny of desired genotypes. Age-matched isogenic 
germ-free and conventional mouse intestinal tissue samples were provided by Dr. Justin 
Sonnenburg’s lab (Stanford University, Stanford, CA).    
 
ALP Activity Assay 
1 cm segments of the proximal duodenum from mice were collected and cut open 
longitudinally. The lumen side was gently washed with PBS. Cells on the lumen side 
were harvested using cell scrapers, homogenized in 1 ml lysis buffer (50 mM Tris-HCl 
(pH 7.6), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100), and centrifuged 
at 14,000 rpm for 15 min at 4
°
C. The cell-free supernatant was diluted in double distilled 
H2O (ddH2O) and protein concentration was measured using the Bio-Rad protein assay 
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kit (Bio-Rad Laboratories Inc.). Mouse stools were collected, weighed and homogenized 
in 1 ml ddH2O and centrifuged at 14,000 rpm for 15 min at 4
°
C to collect the supernatant. 
Diluted supernatants processed from duodenal samples and stools were assayed for ALP 
activity using the phosphate substrate kit (Thermo Fisher Scientific Inc.). ALP activities 
were normalized to protein concentrations for duodenal samples, and to mass for stools. 
Data were analyzed using the Prism software (GraphPad). 
 
LPS Treatment 
LPS (purified from Salmonella enterica serotype typhimurium, Sigma-Aldrich) 
was dissolved in ddH2O by 2-min sonication. Age-matched female wild type and Akp3
+/-
 
mice were deprived of food for 3 hours, and then weighed to calculate volumes of the 
LPS solution for oral administration. Gavage was done using sterilized 20 G 1 1/2” 
feeding needles (curved, ball-tipped, Popper & Sons) in 8-week and 10-week-old mice, 
and sterilized 14 G 1” needles (straight, ball-tipped, Roboz Surgical Instrument) in 4-
week-old mice. Water gavage was administered to the control group. 3 hours after gavage 
mice were euthanized. 1 cm segments of the proximal duodenum from mice were 
collected for Q-PCR examination of ALPI levels. 2 cm segments of the ileum were 
collected for Q-PCR examination of inflammatory markers. Mice were treated and tissue 
samples were collected at the same time. 
 
Y. pseudotuberculosis Infection 
The wild type Y. pseudotuberculosis strain (YPIII) was provided by Dr. Joan 
Mecsas (Tufts University, Medford, MA). The infection was performed following the 
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protocol described previously (Logsdon and Mecsas, 2003). Briefly, female wild type and 
Akp3
+/-
 mice (10 weeks old) were fasted overnight. Infection was performed by gavage at 
2×10
9
 cfu/animal. Uninfected animals were used as control. 3~5 mice of each group were 
saved for the weight loss study, and weighed daily for 5 days. To quantify bacterial 
colonization, infected mice were euthanized 24 hours after the oral inoculation, and 
Peyer’s patches along the small intestine were collected and homogenized in sterile PBS 
and plated on TSA plates containing 2 μg/ml irgasan to determine cfu/gram of tissue. 
Data were analyzed using the Prism software (GraphPad). 2 cm segments of the ileum 
tissue from mice were collected for Q-PCR examination of inflammatory markers. Mice 
were treated and tissue samples were collected at the same time. 
 
Quantitative PCR (Q-PCR) 
Total RNA was isolated from collected mouse intestinal tissues using the 
PureLink RNA mini kit (Life Technologies Co.) and cDNA was synthesized using the 
SuperScript III first-strand synthesis system (Life Technologies Co.). Quantitative PCR 
was performed on the StepOnePlus real-time PCR system (Life Technologies Co.) using 
the KAPA SYBR fast qPCR kit (Kapa Biosystems). Endogenous reference genes were 
tested, and 36B4, Gapdh and Rpl13a were selected for Q-PCR normalization based on 
the GeNorm and the Normfinder algorithms using the GenEx software (Multid Analyses 
AB). Primers used in Q-PCR were as follows: 36B4fwd, 5’- 
TCCAGGCTTTGGGCATCA-3’; 36B4rev, 5’-
CTTTATCAGCTGCACATCACTCAGA-3’; Gapdhfwd, 5’-
GCACCACCAACTGCTTAGC-3’; Gapdhrev, 5’-GGCATGGACTGTGGTCATGAG-
 24 
 
 
3’; Rpl13afwd, 5’-TTCTGGTATTGGATGGCCGAG-3’; Rpl13arev, 5’- 
ATGTTGATGCCTTCACAGCG-3’; Akp3fwd, 5’- 
ACATTGCTACACAACTCATCTCC-3’; Akp3rev, 5’-
TCCTGCCATCCAATCTGGTTC-3’; Alppl2fwd, 5’-
AATGCCTGCCTCAGCGCTACAGGA-3’; Alppl2rev, 5’-
TGGTCTGGTGTCCCCTTGGGAA-3’; Alpifwd, 5’- 
GGCTACACACTTAGGGGGACCTCCA-3’; Alpirev, 5’-
AGCTTCGGTGACATTGGGCCGGTT-3’; Tnfαfwd, 5’-AGGCTGCCCCGACTACGT-
3’; Tnfαrev, 5’-GACTTTCTCCTGGTATGAGATAGCAAA-3’;Il1βfwd, 5’-
GAAATGCCACCTTTTGACAGTG-3’; Il1βrev, 5’-TGGATGCTCTCATCAGGACAG-
3’; Il6fwd, 5’-TGGTACTCCAGAAGACCAGAGG-3’; Il6rev, 5’-
AACGATGATGCACTTGCAGA-3’; Lcn2fwd, 5’-TGGCCCTGAGTGTCATGTG-3’; 
and Lcn2rev, 5’-CTCTTGTAGCTCATAGATGGTGC-3’. Primer amplification 
efficiency was determined using the LinRegPCR software and incorporated to normalize 
the relative levels of gene expression to endogenous references using the ΔΔCt analysis. 
Data were analyzed using the Prism software (GraphPad). 
 
High Fat Diet (HFD) Feeding 
Male mice of indicated genotypes (at least 10 in each group) from the same 
generation were fed a 36.0% fat diet (Bio-Serv, F3282/S3282) after weanling. HFD 
feeding continued for about 6 months and mouse body weights were recorded weekly. 
Data were analyzed using the Prism software (GraphPad).  
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Results 
Akp3 Is Upregulated by Microbiota 
If Akp3 is upregulated by microbiota, we would expect lower levels of Akp3 in 
mice raised in the absence of microbes (germ-free mice) as compared with those 
colonized normally (conventional mice). We thus measured transcription levels of Akp3 
in the duodenum of age-matched isogenic conventional mice and germ-free mice using 
quantitative real-time PCR (Figure 5A). As expected, we found that germ-free mice had 
significantly lower levels of Akp3 transcription comparing to conventional mice. In 
comparison, no significant differences in Alppl2 or Alpi transcription were observed 
between germ-free and conventional mice. The results were consistent in two 
independent experiments (one shown in Figure 5A), suggesting that the microbiota 
specifically upregulate Akp3. 
We next investigated whether LPS exposure would induce Akp3, similar to the 
regulation of zebrafish alpi.1.We treated wild type mice with water or LPS by oral 
gavage and compared Akp3 transcription levels. Interestingly, oral administration of LPS 
did not stimulate Akp3 in the mouse duodenum (Figure 5B). Furthermore, we found that 
Myd88
-/-
 mice had similar levels of Akp3 transcription to their wild type littermates 
(Figure 5C). Loss of Myd88 has no effects on Akp3 expression, again in contrast to the 
regulation of zebrafish alpi.1. We conclude that whereas the microbiota upregulate Akp3 
in the mouse intestine, the mechanism is different from that in zebrafish.  
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Basal Inflammatory Responses in Akp3
-/-
 Mice Are Comparable to Those in Wild Type 
Mice 
We used the Akp3 loss-of-function mice to study the role of ALPI in modulating 
mouse intestinal inflammatory responses to resident microbiota (basal inflammatory 
responses) during development. We first confirmed that ALPI activities were 
significantly reduced in Akp3
-/-
 mice. The in vitro ALP activity assay showed that as 
compared to the wild type control, Akp3
-/-
 mice had significantly lower ALP activity in 
duodenal epithelia (Figure 6A) and in stools (Figure 6B). The Duodenal ALP deficiency 
is consistent with disruption of Akp3, and the fecal ALP deficiency suggests reduced ALP 
activity throughout the intestine of mutant mice. We detected the ALPI deficiency in 
Akp3
-/-
 mice as early as 2 weeks of age, and the deficit sustained into adulthood. 
Our hypothesis that mouse ALPI ameliorates host inflammatory responses to the 
gut microbiota predicts stronger basal inflammatory responses in Akp3
-/-
 mouse due to 
their low ALPI activity. The duodenum, the proximal portion of the small intestine, is 
sparsely colonized by bacteria (Uhlig and Powrie, 2003) and consequently has the lowest 
levels of inflammatory responses along the length of the intestine (data not shown). Low 
colonization also implies that the immunoregulatory role of Akp3 may be less important 
in the duodenum. In comparison, the ileum, the terminal portion of the small intestine, 
harbors a large population of bacteria and Akp3 could be essential. Since ALPI is secreted 
into the lumen and functions throughout the intestine, we examined basal inflammatory 
responses in the mouse ileum. We measured transcription levels of proinflammatory 
cytokines (Tnf-α, Il-1β and Il-6) and the innate immune protein Lcn2 using quantitative 
real-time PCR, and compared wild type mice to Akp3
-/-
 mice. We detected comparable 
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levels of the four inflammatory markers in ileal samples from wild type and Akp3
-/-
 mice 
of different ages (Figure 7). Loss of Akp3 does not significantly affect basal 
inflammatory responses, suggesting that Akp3 is not required for host immune tolerance 
to commensal microbes.  
 
Akp3 Is Not Required in Defense against Yersinia pseudotuberculosis Infection 
Although disruption of Akp3 has no obvious effect on basal intestinal 
inflammatory responses in healthy animals, we reasoned that the functional requirement 
for Akp3 might be more pronounced when the equilibrium between host and the gut 
microbiota is severely disturbed, as in the case of infection. We speculated that Akp3
-/-
 
mice would be more susceptible to Gram-negative pathogen infection due to their lack of 
ability to dephosphorylate and detoxify LPS. 
Yersinia pseudotuberculosis is a well-studied Gram-negative pathogen that 
colonizes mouse small intestine (Autenrieth and Firsching, 1996; Logsdon and Mecsas, 
2003). We infected 10-week-old wild type and Akp3
-/-
 mice with Y. pseudotuberculosis 
by oral gavage, and monitored animal weight loss over 5 days. We observed similar 
weight loss in wild type and Akp3
-/-
 mice (Figure 8A), suggesting their equal 
susceptibility to infection. To look into the infection dynamics, we examined 
dissemination of Y. pseudotuberculosis into Peyer’s patches along the mouse small 
intestine 24 hours after the initial inoculation. We found that Y. pseudotuberculosis 
colonized at comparable levels in Peyer’s patches of wild type and Akp3-/- mice (Figure 
8B), indicating Akp3 does not prevent translocation of the pathogen. We then assessed 
ileal inflammatory responses of wild type and Akp3
-/-
 mice at this time point, when they 
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were equally colonized. We found that Tnf-α and Il-1β levels were significantly elevated 
in wild type and Akp3
-/-
 mice; Il-6 also seemed to be induced although not significantly 
from the basal level in wild type and Akp3
-/-
 mice; and interestingly, Lcn2 appeared 
significantly upregulated only in Akp3
-/-
 mice, which might suggest increased sensitivity 
of Akp3
-/-
 mice to Y. pseudotuberculosis infection in this specific innate immune response 
(Figure 8C). Taken together, our data demonstrated no immediate requirement of Akp3 in 
defense against Y. pseudotuberculosis infection. 
 
Akp3
-/-
 Mice Develop Immune Tolerance to Low Doses of LPS in the Small Intestine 
We speculated that the large influx of LPS introduced by oral administration of Y. 
pseudotuberculosis might resemble the severe septic shock situation (Morrison and Ryan, 
1987) and that the amount of LPS greatly surpassed the dephosphorylation capacity of 
the mouse intestine, thus masking possible functional requirements for Akp3 to detoxify 
LPS in a less extreme situation. To experimentally test this, we challenged mice with 
high or low doses of LPS.  
First we administered a high dose of LPS (Salmonella typhimurium, 200 mg/kg 
body weight) by oral gavage. We expected this would mimic the Y. pseudotuberculosis 
infection procedure and result in similar inflammatory responses in wild type and Akp3
-/-
 
mice. Indeed, we saw comparable induction of the inflammatory markers Tnf-α, Il-1β and 
Il-6 and Lcn2 by the large dose of LPS in wild type and Akp3
-/-
 mice (Figure 9). 
We next challenged mice with a low dose of LPS (S. typhimurium, 100 mg/kg 
body weight), which we reasoned might be effectively dephosphorylated only in wild 
type mice and result in stronger inflammatory responses in Akp3
-/-
 mutants. On the 
 29 
 
 
contrary, we observed that after the low dose LPS gavage all four inflammatory markers 
examined were significantly upregulated in wild type mice but not in Akp3
-/-
 mice (Figure 
10). Whereas the basal levels of these inflammatory markers were similar in the control 
groups of both genotypes, after LPS gavage wild type mice showed significantly higher 
levels of Tnf-α, Il-1β and Lcn2 in the small intestine than Akp3-/- mice. 
The hyporesponsiveness of the intestinal innate immune system after the low dose 
LPS gavage in adult Akp3
-/-
 mice (10 weeks old) reminded us of a well-recognized 
phenomenon, endotoxin tolerance. Endotoxin/LPS tolerance describes a situation where 
animals or innate immune cells become refractory to endotoxin challenge after a prior 
exposure to small amounts of LPS (Fan and Cook, 2004; Ziegler-Heitbrock, 1995). We 
reasoned that the reduced LPS dephosphorylation activity of Akp3
-/-
 mouse intestine 
resulted in higher concentrations of phosphorylated microbiota-derived LPS, and this 
continuous exposure to more immunostimulatory LPS during development trained mouse 
intestinal innate immune cells to be less responsive to further LPS challenge. To test this 
theory, we examined intestinal inflammatory responses to small doses of LPS in younger 
mice. If there was a process of training, we would not see LPS tolerance at early stages of 
development. As expected, we found that low dose LPS gavage caused similar 
inflammatory responses in the small intestine of wild type and Akp3
-/-
 mice at 19 days 
and 4 weeks old (Figure 11 & 12). Interestingly, 8-week-old Akp3
-/-
 mice exhibited 
“partial” tolerance to the low dose LPS challenge (Figure 13): whereas Tnf-α and Il-1β 
were induced to a similar degree as seen in the wild type mice, Il-6 and Lcn2 levels 
remained low, in contrast to the significant upregulation in the wild type mice. Together, 
our data demonstrated that Akp3
-/-
 mice acquired immune tolerance to low doses of LPS 
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through a long period of development, suggesting a role of Akp3 in educating the 
intestinal immune system.    
 
LPS-Induced Innate Immune Signaling Is Required for the Accelerated Weight Gain of 
Akp3
-/-
 Mice Maintained on HFD 
We proposed that the slightly more active LPS-induced innate immune signaling 
in Akp3
-/-
 mice, stimulated by accumulated intact LPS due to the ALPI deficiency, led to 
faster weight gain when animals were kept on HFD. To test this hypothesis, we asked 
whether the HFD-induced accelerated weight gain in Akp3
-/-
 mice was dependent on their 
ability to sense LPS. We reasoned that if we blocked LPS-sensing in Akp3
-/-
 mice by 
mutating the CD14 co-receptor, they should no longer be affected by the slightly elevated 
phosphorylated LPS levels and should be resistant to the HFD-induced faster weight 
gain. We thus fed HFD to wild type, Akp3
-/-
, CD14
-/-
, and Akp3
-/-
;CD14
-/-
 mice, and 
compared their weight gains over time (Figure 14). As reported, Akp3
-/-
 mice showed 
faster weight gain as compared to wild type mice. But we found that the weight gain 
curve of Akp3
-/-
;CD14
-/-
 mice was statistically indistinguishable from that of wild type or 
CD14
-/-
 mice. The results demonstrate that the LPS-sensing machinery is required for the 
HFD-induced accelerated weight gain in Akp3
-/-
 mice. 
 
Discussion 
Microbiota regulate a great number of genes in animal intestines (Larsson et al., 
2012; Mutch et al., 2004). Here we show that the mouse microbiota specifically 
upregulate Akp3, which could explain its unique expression patterns among mouse ALPI 
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genes. But in contrast to zebrafish where alpi.1 is induced by LPS-mediated innate 
immune signaling (Bates et al., 2007), mouse Akp3 is upregulated by microbiota 
independent of innate immunity. The discrepancy is not surprising considering the 
evolution history of the two ALPI genes (Yang et al., 2012). Akp3 arises from a recent 
duplication of mouse gene Alpi, long after the divergence of zebrafish alpi.1 and mouse 
Alpi. The newly-acquired Akp3 is very likely regulated by different mechanisms from 
alpi.1. In addition, mammals and teleosts have evolved different strategies for immune 
recognition of bacteria (Sullivan et al., 2009), indicating that LPS or the microbiota may 
not act in a conserved way to modulate ALPI genes.  
Microbiota have profound influences on host gut development. Intestinal 
epithelial cell proliferation is reduced in germ-free mice (Uribe et al., 1997). However, 
the reduced Akp3 expression in germ-free mice was unlikely due to their developmental 
defects because otherwise Alppl2 or Alpi would also be downregulated in germ-free mice. 
Instead, we observed that Alppl2 and Alpi were not affected by microbiota colonization. 
Many dietary components like fat (Eliakim et al., 1991; Kaur et al., 2007; Vazquez et al., 
2000), and micronutrients like calcium (Brun et al., 2012), have been reported to 
modulate ALPI expression or activity. We propose that the mouse microbiota upregulate 
Akp3 through metabolic interactions with the host. The gut microbiota perform essential 
metabolic functions that are not encoded in the host genome, including the processing of 
complex proteins and indigestible dietary fibers, and synthesis of vitamins like vitamin K 
(Resta, 2009). Interestingly, vitamin K was reported to induce ALPI activity in rodents 
(Haraikawa et al., 2011; Sogabe et al., 2007). And specifically, oral administration of 
vitamin K boosted ALPI gene expression in the mouse intestine, with a more dramatic 
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effect on Akp3 than Alpi (Haraikawa et al., 2011). We speculate that production of 
vitamin K, which requires the gut microbiota but is independent of host immune 
responses, may be one mechanism by which microbiota upregulate Akp3. And being 
more a potent inducer of Akp3 than Alpi, vitamin K when synthesized by the gut 
microbiota at the physiological levels may only be adequate to significantly elevate Akp3 
expression but not Alpi, which could explain the specific upregulation of Akp3 by 
microbiota.    
Akp3 is not required for establishing immune tolerance to resident microbiota in 
the mouse intestine, as suggested by the similar basal inflammatory responses in wild 
type and Akp3
-/-
 mice. We reasoned that the considerable level of ALP activity retained in 
Akp3
-/-
 mouse intestine, presumably from Alppl2 and Alpi, was adequate to effectively 
prevent excessive inflammatory responses to the gut microbiota. Alppl2 and Alpi are 
reported to be upregulated in Akp3
-/-
 mice (Narisawa et al., 2007). Thus, the ALPI gene 
redundancy and the supplementary mechanism for loss of one gene may combine to keep 
the inflammatory responses in check in Akp3
-/-
 mice. The unaffected basal inflammatory 
responses in the small intestine after disruption of Akp3 also imply, from another 
perspective, the robustness of the equilibrium between host immunity and the gut 
microbiota.  
Exogenous ALPI treatment has been reported to preserve the normal gut barrier 
function (Kaliannan et al., 2013; Ramasamy et al., 2011; Rentea et al., 2012b) and 
prevent gut bacterial translocation after experimental injury in rodent models (Martinez-
Moya et al., 2012). Consistent with the role of ALPI in promoting the gut barrier 
function, disruption of Akp3 caused increased gut permeability (Kaliannan et al., 2013) 
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and more gut bacterial translocation into mesenteric tissues after intestinal 
ischemia/reperfusion injury (Goldberg et al., 2008). Here we observed that Akp3 provided 
no protection against Y. pseudotuberculosis invasion into Peyer’s patches. We think that 
these results are not contradictory but could be representative of the fundamental 
differences between commensal bacteria and virulent pathogens. In the injury models, 
ALPI elicited protective effects by promoting the intestinal epithelial integrity, which was 
competent to block the passive flow-through of the commensal bacteria. However, 
pathogens like Y. pseudotuberculosis have developed sophisticated apparatus to breach 
the gut barrier, making the role of ALPI trivial during infection.   
With respect to intestinal inflammatory responses to Y. pseudotuberculosis 
infection, our results again showed that Akp3 had no beneficial effects. This further 
demonstrated that Akp3 plays little role in defense against the pathogen infection. We 
speculated that the large amount of LPS introduced by Y. pseudotuberculosis inoculation 
exceeded the dephosphorylation and detoxification capacity of the mouse intestine and 
experimentally tested this by administering a high dose of LPS to mice. We showed that 
disruption of Akp3 did not affect mouse intestinal inflammatory responses to the high 
dose LPS, confirming a limited immunoregulatory role of the endogenous ALPI. This 
could explain why exogenous supplementation of ALPI is usually necessary to elicit 
beneficial effects in various injury and disease models.  
Although Akp3 is not required at the host-microbiota equilibrium or in defense 
against Y. pseudotuberculosis infection, we demonstrated an important role of Akp3 in 
educating the mouse immune system. By characterizing intestinal inflammatory 
responses to low doses of LPS in developing animals, we showed that Akp3
-/-
 mice 
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acquired immune tolerance to intestinal LPS through a long period of development and 
that LPS desensitization did not occur until about 8 – 10 weeks of age. We reason that the 
ALPI deficiency in Akp3
-/-
 mice causes increased levels of phosphorylated LPS in the gut 
lumen, which induces a slightly more active innate immune response and in the long term 
trains the intestinal immune system to be less responsive to additional LPS challenge.  
LPS desensitization could benefit Akp3
-/-
 mice by saving energy when mice 
confront commensal gut bacteria, but may also profoundly influence animal responses to 
infections. Mice with induced endotoxin tolerance were reported to be more resistant to 
S. typhimurium and Cryptococcus infections (Lehner et al., 2001; Rayhane et al., 2000), 
yet more susceptible to Escherichia coli (Lu et al., 2008). Correspondingly, S. 
typhimurium was seen to caused more dramatic weight loss and bacterial translocation in 
wild type mice as compared with Akp3
-/-
 mice (Chen et al., 2011). The resistance of Akp3
-
/-
 mice to S. typhimurium infection, in contrast to their similar susceptibility to Y. 
pseudotuberculosis as compared to wild type mice, suggests that these results are 
pathogen-specific. And considering only adult Akp3
-/-
 mice exhibit immune tolerance to 
LPS, their resistance to S. typhimurium infection could also depend on the developmental 
stage. We speculate that adult Akp3
-/-
 mice could be more vulnerable to E. coli infection, 
and Akp3
-/-
 pups that haven’t developed LPS tolerance might not be resistant to S. 
typhimurium infection. 
ALPI activities are inversely related to the obesity proneness in rats receiving 
HFD (de La Serre et al., 2010; Sefcikova et al., 2008). Analogously, mice lacking Akp3 
exhibited accelerated weight gain when maintained on HFD as compared to wild type 
mice (Narisawa et al., 2003). A direct role of mouse ALPI gene Alpi in promoting fatty 
 35 
 
 
acid intake was proposed and upregulation of Alpi in Akp3
-/-
 mice could contribute to the 
HFD-induced faster weight gain (Hansen et al., 2007; Lynes et al., 2011; Narisawa et al., 
2007). However, it is not clear whether the elevation of Akp6 itself is sufficient to cause 
the HFD-induced phenotype in Akp3
-/-
 mice, and other factors may kick in. Here we 
tested the contribution of LPS-induced innate immune signaling and we showed that by 
blocking LPS-sensing we abrogated the faster weight gain of Akp3
-/-
 mice receiving HFD. 
This provides direct evidence that LPS-induced innate immune signaling is required for 
the HFD-induced phenotype of Akp3
-/-
 mice, and implies that a subtle impairment in LPS 
dephosphorylation due to ALPI deficiency can manifest, in the long term, in significant 
physiological differences among individuals. The elevated LPS signaling might also 
underlie the inverse relationship between ALPI activities and the obesity proneness of 
rats receiving HFD and it would be interesting to evaluate contributions of LPS sensing 
in these models.   
In conclusion, we have discovered that the mouse ALPI gene Akp3 is specifically 
upregulated by microbiota, but the mechanisms are different from those observed in 
zebrafish. We have showed that disruption of Akp3 leads to immune desensitization to 
luminal LPS in adult mice, suggesting that Akp3 plays a role in immune education. 
Lastly, we have demonstrated elevated LPS/TLR signaling leads to the HFD-induced 
accelerated weight gain in Akp3
-/-
 mice.  
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CHAPTER IV 
NEONATAL ALPI AND NECROTIZING ENTEROCOLITIS 
 
This chapter includes work that will be published with co-authors, R. Bent and K. 
Guillemin. K. Guillemin designed the research. I performed the experimental work. R. 
Bent organized meconium sample collection. The writing is mine. K. Guillemin provided 
editorial assistance.  
 
Introduction 
Necrotizing enterocolitis (NEC) is a multifactorial disease that predominately 
affects premature infants (Beeby and Jeffery, 1992) and is a leading cause of late 
mortality and morbidity in very preterm infants (Caplan, 2008; Christensen et al., 2010; 
Guthrie et al., 2003; Morgan et al., 2011). Despite advances in neonatal care and medical 
research, the incidence of NEC has increased (Petrosyan et al., 2009) and the mortality 
rate has not significantly changed (Blakely et al., 2005; Holman et al., 1997; Holman et 
al., 2006). The most important risk factor NEC is prematurity (Henry and Moss, 2009) 
and the incidence of NEC is inversely related to an infant’s gestational age (Gregory et 
al., 2011; Lin and Stoll, 2006; Llanos et al., 2002).  
Although the etiology of NEC is not clearly defined (Dominguez and Moss, 2012; 
Gephart et al., 2012), NEC is believed to represent a severe inflammatory disorder in the 
intestine (Ballance et al., 1990; Zhang et al., 2011). Excessive inflammatory responses to 
environmental insults in the immature intestine are a hallmark of NEC (Chan et al., 
2009). Specifically, increased levels of LPS/TLR4 signaling have been suggested to 
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contribute to the pathogenesis of NEC (Chan et al., 2009; Fusunyan et al., 2001; Leaphart 
et al., 2007; Nanthakumar et al., 2011). And inhibition of LPS/TLR4 signaling attenuates 
intestinal inflammation and mitigates NEC pathology in animal models (Chan et al., 
2009; Gribar et al., 2009).  
ALPs been shown by many studies to inhibit LPS-induced TLR4 activation by 
dephosphorylating LPS (Lalles, 2010). Interestingly, a dynamic transition of ALPI 
isozyme forms is associated with the maturation of fetal intestine (Mulivor et al., 1978; 
Sugiura et al., 1981), implying ALPI activity could change with fetal development. We 
hypothesized that ALPI activities in neonates increased with gestational age, i.e., preterm 
neonates have lower ALPI activities than full-term infants. We reasoned that the ALPI 
deficiency in preterm neonates could lead to overactive LPS/TLR4 signaling due to 
decreased LPS-detoxifying activity in the premature intestine colonized by microbes. We 
tested the hypothesis by comparing meconium ALP activities from infants of different 
gestational ages. Meconium, the first stool of a newborn infant, is primarily composed of 
water, intestinal epithelial cells and mucus, and thus provides an accurate measurement of 
the ALP activity in the neonatal intestine.  
 
Materials and Methods 
The use of meconium samples for this study was reviewed by the University of 
Oregon Institutional Review Board and Research Compliance Services and determined to 
qualify for an exemption as per Title 45 CFR Part 46.101 (b)(4). A total of 122 
meconium samples from infants of gestational ages ranging from 24 to 41 weeks were 
collected from the Peacehealth Neonatal Intensive Care Unit and the Peacehealth Nurse 
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Midwifery Birth Center (Springfield, OR). Samples were frozen upon collection and 
subsequently analyzed as follows. The samples were homogenized in double distilled 
H2O and centrifuged at 14,000 rpm for 15 min at 4°C to collect the supernatants. The 
supernatants were then diluted and assayed for protein concentrations using the Bio-Rad 
protein assay kit (Bio-Rad Laboratories Inc.) and ALP activities using the PNPP substrate 
kit (Thermo Fisher Scientific Inc.). ALP activities were compared to standard shrimp 
alkaline phosphatase (Thermo Fisher Scientific Inc.) and normalized to meconium 
protein concentrations. Data were grouped by weeks of completed gestation at birth, and 
plotted using the Prism software (GraphPad software). Correlation between meconium 
ALP activities and gestational age was analyzed using one-way ANOVA (post test for 
linear trend). Meconium ALP deficiency in premature newborns (gestational age ≤ 35 
weeks) was determined using one-way ANOVA (followed by Tukey’s multiple 
comparison test) and one-tailed t-test.    
 
Results and Discussion 
Figure 15 shows the average meconium ALP activities, normalized to total 
protein concentrations, of meconium samples grouped by weeks of gestation. There is a 
strong positive correlation between meconium ALP activity and gestational age (p < 
0.0001; one-way ANOVA and post test for linear trend). When comparing ALP activities 
spanning the gestational age from 24 weeks to 41 weeks, we found the samples were 
statistically separated into two groups, the preterm group (gestational age ≤ 35 weeks) 
and the full-term group (gestational age ≥ 36 weeks) (one-way ANOVA and Tukey’s 
multiple comparison test). A comparison of all meconium samples from full-term infants 
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(gestational age ≥ 36 weeks, n=34), with all samples from premature infants (gestational 
age ≤ 35 weeks, n=88) reveals the latter group to have significantly lower ALP activities 
(p < 0.0001; one-tailed t-test). 
 Our data indicate that premature infants have reduced ALPI activity as compared 
to full-term infants. We speculate that the reduced capacity of preterm infant intestines to 
dephosphorylate proinflammatory LPS may increase the risk of excessive inflammatory 
responses to bacterial colonization and NEC development. Based on these findings, we 
propose that prophylactic ALPI supplementation to premature infants may warrant 
further study as a strategy for decreasing the risk of NEC. Indeed, lab studies using rat 
models have demonstrated the protective effects of ALPI administration against intestinal 
inflammation and injury in experimental NEC (Rentea et al., 2013; Rentea et al., 2012a; 
Rentea et al., 2012b; Riggle et al., 2013; Whitehouse et al., 2010). Future prospective 
studies that record meconium ALPI activities of infants who go on to develop NEC or 
remain healthy may provide additional insights into the possible utility of ALPI 
supplementation for premature neonates.  
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CHAPTER V 
CONCLUSION 
 
We characterized four ALP genes in zebrafish, alpl, alpi.1, alpi.2 and alp3. We 
found the four genes were distributed among three vertebrate ALP gene clades. The 
ALPL clade, which includes zebrafish alpl, remains relatively stable among species. The 
ALPI clade, which includes zebrafish alpi.1 and alpi.2, has undergone rapid evolution. 
And the ALP3 clade, which includes zebrafish alp3, is maintained in teleosts but lost in 
tetrapods. We propose that the distinct evolution histories of the three clades are derived 
from different functional requirements for ALPL versus ALPI. The dramatic changes of 
the ALPI clade in vertebrates imply diversified roles of individual ALPI genes, which we 
have developed reagents and protocols to explore in zebrafish. In mice, we found that the 
ALPI gene Akp3 is specifically induced by microbiota, a process independent of host 
immune recognition of microbiota. We propose that microbiota-mediated metabolic 
functions stimulate Akp3 expression. We show that loss of Akp3 has little effect on 
intestinal inflammatory responses in animals maintained routinely or infected by Y. 
psedotuberclosis, but the ALPI deficiency due to disruption of one ALPI gene causes 
subtle elevation of LPS-mediated innate immune signaling, which in the long term results 
in LPS tolerance and weight gain. And finally, we report a positive correlation between 
meconium ALP activity and gestational age, suggesting preterm neonates have reduced 
ALPI activity, which could predispose them to inflammation and NEC.       
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APPENDIX 
FIGURES 
   
  
Figure 1. Sequence alignment of human and zebrafish ALPs. Identical amino acids 
are shaded gray, putative metal-binding sites are indicated by arrows, active sites are 
underlined, and the conserved serine required for enzyme activity is boxed.  
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Figure 2. Diversification of vertebrate ALP protein sequences. Sequences are 
indicated on this maximum likelihood tree with the species name, gene name, and 
genomic location. For example, the taxon ‘Human ALPL Hsa1:21,835,858’ indicates the 
start of the human ALPL gene encoding this protein on human chromosome 1 at 
nucleotide position 21,835,858 according to Ensembl Release 68 (July 2012) and Pre 
Ensembl Release 66 (April 2012). The tree has three major clades (Alp1 (Alpl clade), 
Alp2 (Alpi clade), and Alp3). Arrows point to the four zebrafish ALP genes.  
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Figure 3. Expression of zebrafish ALP genes. (A) Semi-quantitative reverse 
transcription PCR analysis of alp gene transcript levels at 7 days post fertilization (dpf) in 
whole fish (F), dissected intestines (I), and carcasses with intestine removed (C). In situ 
hybridization of 7 dpf larval sagittal (B, D, E) and transverse (C) sections with probes to 
alpl, alpi.1, alpi.2 and alp3 as indicated. The hybridization is visible in blue. Arrows 
point to the intestinal epithelium.  
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Figure 4. Zebrafish survival curves in infection. Inoculation of rifampicin-resistant E. 
tarda (left) and V. cholera (right) gave rise to reproducible survival curves. Zebrafish 
embryos were inoculated at 3 dpf and mortality was monitored till 8 dpf. Survival curves 
shown were obtained from two independent experiments (A & B).   
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Figure 5. Duodenal transcription levels of mouse ALPI genes. (A) Comparison of 
Akp3, Alppl2 and Alpi levels between 4-week-old control and germ-free mice. (B) 
Comparison of Akp3 transcription levels between 8-week-old control, water-treated, and 
LPS-treated wild type mice. (C) Comparison of Akp3 transcription levels between 4-
week-old wild type and Myd88
-/-
 mice. Error bars represent standard deviations. The 
number below the graph indicates the sample size. Asterisks mark the significant 
difference (***, p < 0.001; student’s t-test). 
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Figure 6. Mouse ALPI activities. Comparison of ALP activities between wild type and 
Akp3
-/-
 mice in (A) duodenal epithelia (dALP) and (B) stools (sALP), at different ages as 
indicated at the top of each bar graph. Error bars represent standard deviations. The 
number below the graph indicates the sample size. Asterisks mark the significant 
difference (**, p < 0.01; ***, p < 0.001; student’s t-test). 
 
 
 
 
 
 
 
 
 
 47 
 
 
 
 
Figure 7. Basal intestinal inflammatory responses. Comparison of ileal transcriptional 
levels of Tnf-α, Il-1β, Il-6 and Lcn2 between wild type (white column) and Akp3-/- mice 
(black column) at different ages. Error bars represent standard deviations. The number 
below the graph indicates the sample size. 
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Figure 8. Yersinia pseudotuberculosis infection. (A) Body weight curves of control or 
infected wild type and Akp3
-/-
 mice. Error bars represent standard deviations. (B)  
Colonization of Yersinia pseudotuberculosis in Peyer’s patches. Each dot represents a 
mouse. (C) Real-time PCR quantification of transcription levels of Tnf-α, Il-1β, Il-6 and 
Lcn2 in the small intestine of control or infected wild type and Akp3
-/-
 mice (10 weeks 
old). Error bars represent standard deviations.  The number below the graph indicates the 
sample size. Asterisks mark the significant difference (*, p < 0.05; **, p < 0.01; one-way 
ANOVA followed by Bonferroni test). 
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Figure 9. High dose LPS treatment in 10-week-old mice. Real-time PCR 
quantification of transcription levels of Tnf-α, Il-1β, Il-6 and Lcn2 in the small intestine 
of water- or high dose LPS-treated wild type and Akp3
-/-
 mice (10 weeks old). Error bars 
represent standard deviations.  The number below the graph indicates the sample size. 
Asterisks mark the significant difference (*, p < 0.05; one-way ANOVA followed by 
Bonferroni test). 
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Figure 10. Low dose LPS treatment in 10-week-old mice. Real-time PCR 
quantification of transcription levels of Tnf-α, Il-1β, Il-6 and Lcn2 in the small intestine 
of water- or low dose LPS-treated wild type and Akp3
-/-
 mice (10 weeks old). Error bars 
represent standard deviations.  The number below the graph indicates the sample size. 
Asterisks mark the significant difference (*, p < 0.05; **, p < 0.01; ***, p < 0.001; one-
way ANOVA followed by Bonferroni test). 
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Figure 11. Low dose LPS treatment in 19-day-old mice. Real-time PCR quantification 
of transcription levels of Tnf-α, Il-1β, I-l6 and Lcn2 in the small intestine of water- or 
low dose LPS-treated wild type and Akp3
-/-
 mice at 19 days old. Error bars represent 
standard deviations.  The number below the graph indicates the sample size. Asterisks 
mark the significant difference (*, p < 0.05; one-way ANOVA followed by Bonferroni 
test). 
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Figure 12. Low dose LPS treatment in 4-week-old mice. Real-time PCR quantification 
of transcription levels of Tnf-α, Il-1β, I-l6 and Lcn2 in the small intestine of water- or 
low dose LPS-treated wild type and Akp3
-/-
 mice at 4 weeks old. Error bars represent 
standard deviations.  The number below the graph indicates the sample size. Asterisks 
mark the significant difference (*, p < 0.05; one-way ANOVA followed by Bonferroni 
test). 
 
 
 
 
 
 
 53 
 
 
 
 
 
 
Figure 13. Low dose LPS treatment in 8-week-old mice. Real-time PCR quantification 
of transcription levels of Tnf-α, Il-1β, I-l6 and Lcn2 in the small intestine of water- or 
low dose LPS-treated wild type and Akp3
-/-
 mice at 8 weeks old. Error bars represent 
standard deviations.  The number below the graph indicates the sample size. Asterisks 
mark the significant difference (*, p < 0.05; **, p < 0.01; one-way ANOVA followed by 
Bonferroni test). 
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Figure 14. Weight gains of mice receiving HFD . Weight gains of wild type, Akp3
-/-
, 
CD14
-/-
, and Akp3
-/-
;CD14
-/-
 mice on HFD. Error bars represent standard deviations. 
Asterisks mark the significant difference (***, p < 0.001; two-way ANOVA). 
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Figure 15. Meconium ALP activity is positively related to gestational age. Meconium 
ALP activities increased with gestational age (p < 0.0001; one-way ANOVA and post test 
for linear trend). Samples were statistically separated into two different groups, A and B 
(one-way ANOVA and Tukey’s multiple comparison test). Preterm infants (group A, 
gestational age ≤ 35 weeks) had significantly lower meconium ALP activities than full-
term infants (group B, gestational age ≥ 36 weeks) (***, p < 0.0001; one-tailed t-test). 
Error bars represent standard deviations. Numbers in columns indicate sample sizes.  
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